INVO Bioscience Regains Full U.S. Commercialization Rights

/PRNewswire/ -- INVO Bioscience, Inc. ("INVO" or the "Company") (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo...

November 8, 2021 1 min read

/PRNewswire/ — INVO Bioscience, Inc. (“INVO” or the “Company”) (NASDAQ: INVO), a medical device company focused on commercializing the world’s only in vivo…